(Diane Mulligan) - Small cell lung cancer (SCLC) is among the most aggressive, deadliest forms of lung cancer, yet it’s still too often overlooked. For decades, treatment options were limited, offering little hope to those diagnosed with SCLC, until now.

In 2013, Congress passed legislation that mandated the National Cancer Institute create a scientific plan for treating patients with less than a 50% chance of surviving 5 years. This included SCLC. With this focus on research, SCLC, once considered a hopeless diagnosis because of its swift spread and resistance to standard treatment, is now seeing real momentum. Breakthrough research has increased the number of treatment options by 67% giving doctors new tools and patients new reasons to hope.

Because of research, treatments like the r

See Full Page